T36.6X2A Poisoning by rifampicins, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by rifampicins, intentional self-harm, initial encounter

Summary

This condition describes intentional self-harm poisoning by rifampicins during an initial encounter. It applies when rifampicin exposure results in harmful effects due to deliberate overdose or self-inflicted exposure. Documentation should specify the intentional nature of the event and encounter details (initial encounter) to guide accurate coding.

Causes

Intentional self-harm poisoning may result from deliberate overdose or self-inflicted exposure to rifampicins. This can occur due to suicidal intent, self-harm behaviors, or misuse of the medication. Adverse effects may stem from idiosyncratic reactions or drug interactions, though the focus here is on intentional exposure.

Risk Factors

• Prior history of rifampicin sensitivity or allergies.
• Mental health conditions increasing self-harm risk.
• Access to rifampicin medications.
• Substance use disorders.
• Prior self-harm or suicidal ideation.

Symptoms

• Gastrointestinal: Nausea, vomiting, abdominal pain, diarrhea.
• Allergic: Rash, urticaria, or anaphylaxis in severe cases.
• Systemic: Fever, hypotension, or hepatotoxicity.
• Neurological: Dizziness, confusion, or seizures in severe poisoning.
• Behavioral: Evidence of intentional self-harm.

Diagnosis

Evaluation includes patient history of rifampicin exposure, clinical assessment of symptoms, and toxicology screening. Laboratory tests may assess liver function, renal function, and drug levels. Documentation must confirm intentional self-harm and initial encounter status.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying mental health needs. Interventions may include activated charcoal, supportive care, and psychiatric evaluation. Specific antidotes for rifampicin poisoning are not available.

Prognosis and Follow-Up

Prognosis depends on the dose ingested, time to treatment, and patient factors. Follow-up includes monitoring for delayed toxicity and coordinating mental health support. Long-term outcomes vary based on the severity of poisoning and underlying conditions.

Complications

• Severe hepatotoxicity or organ failure.
• Neurological damage from prolonged exposure.
• Recurrent self-harm or suicidal behavior.
• Drug interactions exacerbating toxicity.

Lifestyle & Prevention

• Secure storage of rifampicin medications.
• Patient education on safe medication use.
• Mental health support for at-risk individuals.
• Regular medication reviews to prevent misuse.

When to Seek Professional Help

Seek immediate medical attention for suspected intentional self-harm poisoning. Signs include altered mental status, severe gastrointestinal symptoms, or evidence of self-inflicted injury. Prompt care is critical to reduce complications.

Tips for Medical Coders

Document the intentional self-harm nature of the poisoning and confirm the initial encounter status. Ensure details about rifampicin exposure, clinical findings, and treatment are clearly recorded to support accurate coding.